Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 11
1995 5
1996 13
1997 14
1998 18
1999 21
2000 34
2001 26
2002 31
2003 37
2004 23
2005 26
2006 25
2007 39
2008 32
2009 37
2010 42
2011 45
2012 50
2013 55
2014 36
2015 38
2016 32
2017 36
2018 45
2019 31
2020 33
2021 14
2022 5
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

799 results

Results by year

Filters applied: . Clear all
Page 1
A human memory T cell subset with stem cell-like properties.
Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP. Gattinoni L, et al. Nat Med. 2011 Sep 18;17(10):1290-7. doi: 10.1038/nm.2446. Nat Med. 2011. PMID: 21926977 Free PMC article.
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents.
Riether C, Pabst T, Höpner S, Bacher U, Hinterbrandner M, Banz Y, Müller R, Manz MG, Gharib WH, Francisco D, Bruggmann R, van Rompaey L, Moshir M, Delahaye T, Gandini D, Erzeel E, Hultberg A, Fung S, de Haard H, Leupin N, Ochsenbein AF. Riether C, et al. Nat Med. 2020 Sep;26(9):1459-1467. doi: 10.1038/s41591-020-0910-8. Epub 2020 Jun 29. Nat Med. 2020. PMID: 32601337 Clinical Trial.
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.
Jaeger-Ruckstuhl CA, Lo Y, Fulton E, Waltner OG, Shabaneh TB, Simon S, Muthuraman PV, Correnti CE, Newsom OJ, Engstrom IA, Kanaan SB, Bhise SS, Peralta JMC, Ruff R, Price JP, Stull SM, Stevens AR, Bugos G, Kluesner MG, Voillet V, Muhunthan V, Morrish F, Olson JM, Gottardo R, Sarthy JF, Henikoff S, Sullivan LB, Furlan SN, Riddell SR. Jaeger-Ruckstuhl CA, et al. Immunity. 2024 Feb 13;57(2):287-302.e12. doi: 10.1016/j.immuni.2024.01.011. Immunity. 2024. PMID: 38354704 Free article.
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.
Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware CF, Malinin NL, Wallach D, Yagita H, Okumura K. Akiba H, et al. J Biol Chem. 1998 May 22;273(21):13353-8. doi: 10.1074/jbc.273.21.13353. J Biol Chem. 1998. PMID: 9582383 Free article.
Targeting CD70 for human therapeutic use.
Boursalian TE, McEarchern JA, Law CL, Grewal IS. Boursalian TE, et al. Adv Exp Med Biol. 2009;647:108-19. doi: 10.1007/978-0-387-89520-8_7. Adv Exp Med Biol. 2009. PMID: 19760069 Review.
The role of CD27 in anti-viral T-cell immunity.
Grant EJ, Nüssing S, Sant S, Clemens EB, Kedzierska K. Grant EJ, et al. Curr Opin Virol. 2017 Feb;22:77-88. doi: 10.1016/j.coviro.2016.12.001. Epub 2017 Jan 12. Curr Opin Virol. 2017. PMID: 28086150 Review.
799 results